Tokyo, Japan

Takafumi Okutomi

This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Meiji Seika Kaisha, Ltd.. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takafumi Okutomi. Retrieved from https://idiyas.com/inventor/takafumi-okutomi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takafumi Okutomi: Innovator in Protein and Peptide Antigens

Introduction

Takafumi Okutomi is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of protein and peptide antigens. His work is aimed at enhancing the diagnosis, prevention, and treatment of various diseases.

Latest Patents

Takafumi Okutomi holds a patent for a protein or peptide derived from outer membrane protein PA0427. This invention includes an antibody against the protein or peptide, which is intended for use in the diagnosis, prevention, or treatment of diseases associated with it. His innovative approach has the potential to impact medical practices significantly.

Career Highlights

Okutomi is associated with Meiji Seika Kaisha, Ltd., where he continues to advance his research and development efforts. His work at the company reflects his commitment to improving healthcare through scientific innovation.

Collaborations

He has collaborated with notable colleagues, including Jiro Tanaka and Fukuichi Ohsawa, to further enhance the scope and impact of his research.

Conclusion

Takafumi Okutomi's contributions to the field of biotechnology through his patent and collaborative efforts highlight his role as an influential inventor. His work continues to pave the way for advancements in medical diagnostics and treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…